ORIZURU THERAPEUTICS
Orizuru Therapeutics is a cell-related technology firm that provides regenerative medicine and cell transplantation.
ORIZURU THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2021-04-09
Address:
Japan, Jawa Tengah, Indonesia
Country:
Indonesia
Website Url:
http://www.orizuru-therapeutics.com
Status:
Active
Similar Organizations
Aspron Healthcare
Aspron Healthcare is a pharmaceutical company that produces generic medicines.
Xellera Therapeutics
Xellera Therapeutics is a biotechnology company discovers and develops therapeutic and regenerative medicine for the treatment of diseases.
Official Site Inspections
http://www.orizuru-therapeutics.com
- Host name: ec2-52-194-35-217.ap-northeast-1.compute.amazonaws.com
- IP address: 52.194.35.217
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Orizuru Therapeutics"
ORIZURU THERAPEUTICS
Orizuru Therapeutics promotes the social implementation of cell therapy products and innovative iPS cell-related technologies (platform innovation). Company Overview Scope of Business 1. …See details»
Orizuru Therapeutics - Crunchbase Company Profile
Orizuru Therapeutics is a cell-related technology firm that provides regenerative medicine and cell transplantation.See details»
The Forum for Innovative Regenerative Medicine (FIRM) Ver.1.0 …
Info Sheet for Technical description Ver.1.0 Organization ... No. 0009 * Mandatoty fields What kind of technology do you want to offer? *See details»
Orizuru Therapeutics, Inc. - LinkedIn
Orizuru Therapeutics, Inc. | 188 followers on LinkedIn. R&D-driven company developing iPSCs to cure life-threatening diseases with large unmet needs. | This company is a spinout from …See details»
Orizuru Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Orizuru Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
#22 Realizing Clinical Application of iPS Cells and …
Orizuru Therapeutics is an R&D-oriented company specializing in the commercialization of regenerative medicine derived from iPS cells, and based on its world-class scientific and technological expertise in iPS cells and cell …See details»
Kentaro Tomita - Principal Scientist - Orizuru …
Principal Scientist - Orizuru Therapeutics · Experience: Orizuru Therapeutics, Inc. · Education: Osaka University · Location: Brookline · 12 connections on LinkedIn. View Kentaro Tomita’s ...See details»
ORIZURU THERAPEUTICS
Aug 10, 2021 ORIZURU THERAPEUTICSのOrizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative Medicineのペー …See details»
Establishment of Orizuru Therapeutics K.K. and Investment in the ...
Aug 10, 2021 Orizuru Tx is an organization of approximately 60 employees. Each employee has cutting-edge iPS cell technology and know-how, as well as outstanding experience in …See details»
Orizuru Therapeutics - VentureRadar
Private Company "Orizuru Therapeutics promotes the social implementation of cell therapy products and innovative iPS cell related technologies (platform innovation). We are developing …See details»
Orizuru Therapeutics - Products, Competitors, Financials, …
About Orizuru Therapeutics Orizuru Therapeutics is a biotechnology company focused on regenerative medicine within the healthcare sector. The company specializes in the …See details»
Orizuru Therapeutics, Inc. (Orizuru Therapeutics, Inc.) - 药物管线_ …
了解Orizuru Therapeutics, Inc. (Orizuru Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的6篇文献，疾病领域:免疫系统疾病，内分泌与代谢疾病，技术平台:诱导性多能干细 …See details»
Orizuru Therapeutics Boots Up to Take Over iPSC Assets from T …
Aug 11, 2021 Orizuru Therapeutics has been launched as a new company specializing in the development of iPSC-based regenerative medicine and other technological applications in the …See details»
Innovative Functional Peptides Successfully Co-Developed as ...
Jan 29, 2025 Orizuru Therapeutics, Inc. (OZTx), a Japanese biotechnology company focusing on the research and development of iPSC-derived regenerative medicine, and PeptiGrowth …See details»
Orizuru Therapeutics Launches as R&D Company Focused on …
Aug 15, 2021 Contributing to society and patients through the utilization of iPSC technology developed in Japan New company to advance two successful outcomes from T-CiRA …See details»
Orizuru Therapeutics Launches Operations as Research and …
Jun 1, 2021 iPSC-based medicine KYOTO, Japan, Aug. 10, 2021 /PRNewswire/ -- Orizuru Therapeutics Launches Operations as Research and Development-driven Company for …See details»
ORIZURU THERAPEUTICS
6 days ago ORIZURU THERAPEUTICSの第24回日本再生医療学会総会シンポジウムに登壇いたしますのページです。Just another WordPress siteSee details»
Orizuru Therapeutics Launches Operations as Research and …
Aug 10, 2021 Orizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative MedicineSee details»
Orizuru Therapeutics Launches Operations as Research and …
Orizuru Therapeutics Inc. announced the launch of its operations on June 1, 2021. OZTx is a research and development-driven company focusing on the development of iPSC―based …See details»
ORIZURU THERAPEUTICS
Dec 23, 2024 ORIZURU THERAPEUTICSのAMED公募課題 令和6年度「再生・細胞医療・遺伝子治療産業化促進事業」採択のお知らせのページです。See details»